サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1353584

関節内補充療法の世界市場規模、シェア、産業動向分析レポート：用途別、製品別、最終用途別、地域別展望と予測、2023年～2030年

Global Viscosupplementation Market Size, Share & Industry Trends Analysis Report By Application, By Product (Three Injection, Single Injection, and Five Injection), By End-use, By Regional Outlook and Forecast, 2023 - 2030
出版日: | 発行: KBV Research | ページ情報: 英文 241 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節内補充療法の世界市場規模、シェア、産業動向分析レポート：用途別、製品別、最終用途別、地域別展望と予測、2023年～2030年
出版日: 2023年08月31日
発行: KBV Research
ページ情報: 英文 241 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

関節内補充療法市場規模は、予測期間中にCAGR 8.6％で成長し、2030年までに82億米ドルに達すると予測されます。

しかし、変形性関節症の患者は不快感を緩和するためにOTCや処方箋のNSAIDsを使用するのが一般的です。2019 National Center for Biotechnology Informationのレポートによると、米国では変形性関節症患者の50％以上にNSAIDsが投与されています。欧州では、処方薬を受けている変形性関節症患者の60％（47％）がNSAIDsを処方されています。NSAIDsの使用は心血管系の有害事象のリスクを高める。患者のCVDリスクは、シクロオキシゲナーゼ（COX）-2選択的NSAIDs（コキシブ）および非選択的NSAIDsによって上昇します。心不全（HF）、血圧上昇、心房細動、静脈血栓塞栓症はさらに患者にとって重要なイベントです。この要因は市場にとって課題となります。さらに、関節内補充療法の市場拡大はCOVID-19の発生によって悪影響を受けた。関節内補充療法は緊急性を要しない処置であったため、COVID-19の大流行時にはほとんどの処置が中止または延期されました。そのため、関節内補充療法の需要が減少し、市場の拡大が妨げられました。関節内補充療法製品のユーザーのほとんどが高齢者であるため、市場も大きな影響を受けた。このグループは一般的に、感染のリスクを下げるために自宅待機を勧められていました。

用途別展望

用途別に見ると、市場は変形性膝関節症、変形性手関節症、変形性股関節症、その他に分けられます。変形性膝関節症セグメントは、2022年の市場で最大の収益シェアを獲得しました。最近の平均寿命や肥満度（BMI）の改善により、変形性膝関節症（OA）が一般的になったと考えられています。機械的な負担や炎症によって関節の組織が破壊されることが、膝OAの主な原因であることを示す有力な証拠があります。

製品の展望

製品によって、市場は単回注射、3回注射、5回注射に分類されます。単回注射セグメントは、2022年の市場でかなりの収益シェアを占めています。予測期間中、単回注射セグメントが最も急速に増加すると予測されます。これらの注射は市場では比較的新しいものであるが、レジメンが短く、通院回数が少なく、副作用がなく、不快感が少ないことから急速に成長しています。

最終用途の展望

最終用途に基づき、市場は病院と整形外科クリニック／ASCに二分されます。2022年には、整形外科クリニック／ASC分野が市場で最大の収益シェアを占める。ASCはACL再建術、股関節、膝関節、肩関節の置換術などの手術を即日行うことができるため、クリニック／ASC部門は最も急速に拡大すると予測されています。これらの手術はそれほど複雑ではなく、入院も最小限で済みます。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAにまたがって分析されます。2022年には、アジア太平洋地域が最も高い収益シェアを獲得し、市場を独占しました。この地域の市場を押し上げる主な要因の1つは、変形性関節症になりやすい高齢者人口の存在です。さらに、アジア太平洋地域の多くの人々は、文化的信条、手術に対する恐怖心、術後の合併症を避けたいという願望から、手術以外の治療法を好んでいます。関節内補充療法は、人工関節置換術のような外科的介入に代わる、低侵襲の選択肢を提供します。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場の概要

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
  • ポーターのファイブフォース分析

第4章 世界の関節内補充療法市場：用途別

  • 世界の変形性膝関節症市場：地域別
  • 手の変形性関節症の世界市場：地域別
  • 世界の変形性股関節症市場：地域別
  • 世界のその他の市場：地域別

第5章 世界の関節内補充療法市場：製品別

  • 世界の3回注射市場：地域別
  • 世界の単回注射市場：地域別
  • 世界のファイブインジェクション市場：地域別

第6章 世界の関節内補充療法市場：最終用途別

  • 世界の病院市場：地域別
  • 世界の整形外科クリニック/ASC市場：地域別

第7章 世界の関節内補充療法市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第8章 企業プロファイル

  • DePuy Synthes（Johnson & Johnson）
  • Sanofi SA
  • Zimmer Biomet Holdings, Inc
  • Ferring Holdings SA
  • F Hoffmann-La Roche Ltd.
  • LG Chem Ltd（LG Corporation）
  • Anika Therapeutics, Inc
  • Fidia Farmaceutici Sp.A.（P&R Farmaceutici S.p.A）
  • Smith & Nephew PLC
  • Seikagaku Corp

第9章 関節内補充療法市場での勝利は必須

図表

LIST OF TABLES

  • TABLE 1 Global Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 2 Global Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 3 Global Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 4 Global Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 5 Global Knee Osteoarthritis Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Knee Osteoarthritis Market by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Hand Osteoarthritis Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Hand Osteoarthritis Market by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Hip Osteoarthritis Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Hip Osteoarthritis Market by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 14 Global Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 15 Global Three Injection Market by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Three Injection Market by Region, 2023 - 2030, USD Million
  • TABLE 17 Global Single Injection Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Single Injection Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Five Injection Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Five Injection Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 22 Global Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 23 Global Hospitals Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Hospitals Market by Region, 2023 - 2030, USD Million
  • TABLE 25 Global Orthopedic Clinics/ASCs Market by Region, 2019 - 2022, USD Million
  • TABLE 26 Global Orthopedic Clinics/ASCs Market by Region, 2023 - 2030, USD Million
  • TABLE 27 Global Viscosupplementation Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Viscosupplementation Market by Region, 2023 - 2030, USD Million
  • TABLE 29 North America Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 30 North America Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 31 North America Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 32 North America Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 33 North America Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 34 North America Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 35 North America Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 36 North America Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 37 North America Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 38 North America Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 39 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 42 North America Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 43 North America Three Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Three Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Single Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Single Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Five Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Five Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 49 North America Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 50 North America Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 51 North America Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
  • TABLE 54 North America Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
  • TABLE 55 North America Viscosupplementation Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Viscosupplementation Market by Country, 2023 - 2030, USD Million
  • TABLE 57 US Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 58 US Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 59 US Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 60 US Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 61 US Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 62 US Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 63 US Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 64 US Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 65 Canada Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 66 Canada Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 67 Canada Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 68 Canada Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 69 Canada Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 70 Canada Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 71 Canada Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 72 Canada Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 73 Mexico Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 74 Mexico Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 75 Mexico Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 76 Mexico Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 77 Mexico Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 78 Mexico Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 79 Mexico Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 80 Mexico Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 81 Rest of North America Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 82 Rest of North America Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 83 Rest of North America Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 84 Rest of North America Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 85 Rest of North America Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 86 Rest of North America Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 87 Rest of North America Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 88 Rest of North America Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 89 Europe Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 90 Europe Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 91 Europe Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 92 Europe Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 93 Europe Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 94 Europe Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 95 Europe Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 96 Europe Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 97 Europe Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 98 Europe Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 99 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 100 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 101 Europe Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 102 Europe Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 103 Europe Three Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 104 Europe Three Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 105 Europe Single Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Single Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 107 Europe Five Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Five Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 109 Europe Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 110 Europe Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 111 Europe Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
  • TABLE 115 Europe Viscosupplementation Market by Country, 2019 - 2022, USD Million
  • TABLE 116 Europe Viscosupplementation Market by Country, 2023 - 2030, USD Million
  • TABLE 117 Germany Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 118 Germany Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 119 Germany Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 120 Germany Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 121 Germany Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 122 Germany Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 123 Germany Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 124 Germany Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 125 UK Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 126 UK Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 127 UK Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 128 UK Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 129 UK Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 130 UK Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 131 UK Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 132 UK Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 133 France Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 134 France Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 135 France Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 136 France Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 137 France Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 138 France Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 139 France Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 140 France Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 141 Russia Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 142 Russia Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 143 Russia Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 144 Russia Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 145 Russia Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 146 Russia Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 147 Russia Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 148 Russia Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 149 Spain Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 150 Spain Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 151 Spain Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 152 Spain Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 153 Spain Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 154 Spain Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 155 Spain Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 156 Spain Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 157 Italy Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 158 Italy Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 159 Italy Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 160 Italy Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 161 Italy Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 162 Italy Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 163 Italy Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 164 Italy Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 165 Rest of Europe Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 166 Rest of Europe Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 167 Rest of Europe Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 168 Rest of Europe Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 169 Rest of Europe Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 170 Rest of Europe Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 171 Rest of Europe Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 172 Rest of Europe Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 173 Asia Pacific Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 174 Asia Pacific Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 175 Asia Pacific Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 176 Asia Pacific Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 177 Asia Pacific Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 178 Asia Pacific Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 179 Asia Pacific Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 180 Asia Pacific Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 181 Asia Pacific Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 182 Asia Pacific Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 183 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 184 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 185 Asia Pacific Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 186 Asia Pacific Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 187 Asia Pacific Three Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 188 Asia Pacific Three Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 189 Asia Pacific Single Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 190 Asia Pacific Single Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 191 Asia Pacific Five Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific Five Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 193 Asia Pacific Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 194 Asia Pacific Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 195 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 196 Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 197 Asia Pacific Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
  • TABLE 198 Asia Pacific Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
  • TABLE 199 Asia Pacific Viscosupplementation Market by Country, 2019 - 2022, USD Million
  • TABLE 200 Asia Pacific Viscosupplementation Market by Country, 2023 - 2030, USD Million
  • TABLE 201 China Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 202 China Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 203 China Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 204 China Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 205 China Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 206 China Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 207 China Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 208 China Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 209 Japan Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 210 Japan Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 211 Japan Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 212 Japan Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 213 Japan Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 214 Japan Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 215 Japan Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 216 Japan Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 217 India Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 218 India Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 219 India Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 220 India Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 221 India Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 222 India Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 223 India Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 224 India Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 225 South Korea Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 226 South Korea Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 227 South Korea Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 228 South Korea Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 229 South Korea Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 230 South Korea Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 231 South Korea Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 232 South Korea Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 233 Singapore Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 234 Singapore Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 235 Singapore Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 236 Singapore Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 237 Singapore Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 238 Singapore Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 239 Singapore Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 240 Singapore Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 241 Malaysia Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 242 Malaysia Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 243 Malaysia Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 244 Malaysia Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 245 Malaysia Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 246 Malaysia Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 247 Malaysia Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 248 Malaysia Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 249 Rest of Asia Pacific Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 250 Rest of Asia Pacific Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 251 Rest of Asia Pacific Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 252 Rest of Asia Pacific Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 253 Rest of Asia Pacific Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 254 Rest of Asia Pacific Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 255 Rest of Asia Pacific Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 256 Rest of Asia Pacific Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 257 LAMEA Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 258 LAMEA Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 259 LAMEA Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 260 LAMEA Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 261 LAMEA Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 262 LAMEA Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 263 LAMEA Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 264 LAMEA Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 265 LAMEA Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 266 LAMEA Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 267 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 268 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 269 LAMEA Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 270 LAMEA Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 271 LAMEA Three Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 272 LAMEA Three Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 273 LAMEA Single Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 274 LAMEA Single Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 275 LAMEA Five Injection Market by Country, 2019 - 2022, USD Million
  • TABLE 276 LAMEA Five Injection Market by Country, 2023 - 2030, USD Million
  • TABLE 277 LAMEA Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 278 LAMEA Viscosupplementation Market by End-use, 2023 - 2030, USD Million
  • TABLE 279 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 280 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 281 LAMEA Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
  • TABLE 282 LAMEA Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
  • TABLE 283 LAMEA Viscosupplementation Market by Country, 2019 - 2022, USD Million
  • TABLE 284 LAMEA Viscosupplementation Market by Country, 2023 - 2030, USD Million
  • TABLE 285 Brazil Viscosupplementation Market, 2019 - 2022, USD Million
  • TABLE 286 Brazil Viscosupplementation Market, 2023 - 2030, USD Million
  • TABLE 287 Brazil Viscosupplementation Market by Application, 2019 - 2022, USD Million
  • TABLE 288 Brazil Viscosupplementation Market by Application, 2023 - 2030, USD Million
  • TABLE 289 Brazil Viscosupplementation Market by Product, 2019 - 2022, USD Million
  • TABLE 290 Brazil Viscosupplementation Market by Product, 2023 - 2030, USD Million
  • TABLE 291 Brazil Viscosupplementation Market by End-use, 2019 - 2022, USD Million
  • TABLE 292 Brazil Viscosupplementation Market by End-use, 2023 - 2030, USD Million
目次

The Global Viscosupplementation Market size is expected to reach $8.2 billion by 2030, rising at a market growth of 8.6% CAGR during the forecast period.

The North America region will capture around 30% share in the market by 2030. Due to factors like the increasing incidence of osteoarthritis and related disorders, the growing geriatric population, the well-developed healthcare infrastructure, and increasing demand for non-surgical procedures. The demand for viscosupplementation is increasing due to the rising prevalence of arthritis, osteoarthritis, and knee pain. Some of the factors impacting the market are increased demand for minimally invasive therapies, increasing elderly population with osteoarthritis, and increase in cardiovascular risk due to use of NSAIDs for osteoarthritis.

Less pain, fewer complications, and a shortened hospital stay are associated with minimally invasive surgery. Minimally invasive surgical techniques are used to perform procedures in the fields of cardiothoracic surgery, gastroesophageal reflux disease, gastroenterology, gynecological surgery, heart surgery, pediatric surgery, urogynecology and pelvic reconstructive surgery, and urological surgery. Minimally invasive procedures can be used for both diagnostic and therapeutic procedures. Furthermore, due to age-related changes in the body, such as impaired cartilage repair capacity and changes in joint structure, which contribute to the disease's development and progression, elderly persons are more prone to various health issues, including osteoarthritis. The incidence of OA is predicted to increase, putting a substantial burden on people, health systems, and social care systems around the world due to the rise in the geriatric population and the high prevalence of obesity. According to the Arthritis Foundation, osteoarthritis will affect 130 million people globally by 2050. Therefore, the rising demand for minimally invasive therapy and growth in the number of elderly populations with osteoarthritis will aid in increasing demand for viscosupplementation treatments, thereby driving market growth.

However, patients with osteoarthritis commonly use OTC and prescription NSAIDs to alleviate discomfort. According to a 2019 National Center for Biotechnology Information report, NSAIDs are administered to more than 50% of osteoarthritis patients in the US. In Europe, 60% of osteoarthritis patients receiving prescription medications (47%) were prescribed NSAIDs. The use of NSAIDs raises the risk of adverse cardiovascular events. Patients' CVD risk is increased by cyclooxygenase (COX)-2 selective NSAIDs (coxibs) and non-selective NSAIDs. Heart failure (HF), increased blood pressure, atrial fibrillation, and venous thromboembolism are further patient-important events. This factor poses a challenge for the market. Additionally, market expansion for viscosupplementation was adversely affected by the COVID-19 outbreak. Most procedures were canceled or delayed during the COVID-19 pandemic because viscosupplementation was a non-emergency procedure. It, therefore, reduced the demand for viscosupplementation and prevented market expansion. The market was also significantly impacted because most viscosupplementation product users are senior citizens. This group was generally advised to stay home to lower the risk of infection.

Application Outlook

By application, the market is divided into knee osteoarthritis, hand osteoarthritis, hip osteoarthritis, and others. The knee osteoarthritis segment acquired the maximum revenue share in the market in 2022. Because of recent improvements in life expectancy as well as body mass index (BMI), it is thought that knee osteoarthritis (OA) has become common nowadays. Strong evidence suggests that the breakdown of tissues in joints brought on by mechanical strain and inflammation is the primary cause of knee OA.

Product Outlook

By product, the market is categorized into single injection, three injection, and five injections. The single injection segment covered a considerable revenue share in the market in 2022. Over the projected period, the single-injection segment is anticipated to increase the fastest. These injections are relatively new on the market but are growing quickly due to their shorter regimen, fewer hospital visits, lack of side effects, and low discomfort.

End-use Outlook

Based on end-use, the market is bifurcated into hospitals and orthopedic clinics/ASCs. In 2022 the orthopedic clinics/ASCs segment witnessed the largest revenue share in the market. Due to ASCs' ability to do same-day procedures including ACL reconstruction, hip, knee, and shoulder replacements, among others, the clinics/ASCs segment is also predicted to expand at the quickest rate. These operations are less complex and require minimal hospitalization.

Regional Outlook

Region wise, the market is analyzed across into North America, Europe, Asia Pacific, and LAMEA. In 2022 the Asia Pacific region dominated the market by generating the highest revenue share. One of the key factors boosting the market in this region is the presence of elderly population prone to osteoarthritis. In addition, many individuals in the Asia Pacific region prefer non-surgical treatment options due to cultural beliefs, fear of surgery, and the desire to avoid post-operative complications. Viscosupplementation offers a minimally invasive alternative to surgical interventions like joint replacement.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Knee Osteoarthritis
  • Hand Osteoarthritis
  • Hip Osteoarthritis
  • Others

By Product

  • Three Injection
  • Single Injection
  • Five Injection

By End-use

  • Hospitals
  • Orthopedic Clinics/ASCs

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • DePuy Synthes (Johnson & Johnson)
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.
  • Ferring Holdings SA
  • F. Hoffmann-La Roche Ltd.
  • LG Chem Ltd. (LG Corporation)
  • Anika Therapeutics, Inc.
  • Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
  • Smith & Nephew PLC
  • Seikagaku Corp.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Viscosupplementation Market, by Application
    • 1.4.2 Global Viscosupplementation Market, by Product
    • 1.4.3 Global Viscosupplementation Market, by End-use
    • 1.4.4 Global Viscosupplementation Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. Global Viscosupplementation Market by Application

  • 4.1 Global Knee Osteoarthritis Market by Region
  • 4.2 Global Hand Osteoarthritis Market by Region
  • 4.3 Global Hip Osteoarthritis Market by Region
  • 4.4 Global Others Market by Region

Chapter 5. Global Viscosupplementation Market by Product

  • 5.1 Global Three Injection Market by Region
  • 5.2 Global Single Injection Market by Region
  • 5.3 Global Five Injection Market by Region

Chapter 6. Global Viscosupplementation Market by End-use

  • 6.1 Global Hospitals Market by Region
  • 6.2 Global Orthopedic Clinics/ASCs Market by Region

Chapter 7. Global Viscosupplementation Market by Region

  • 7.1 North America Viscosupplementation Market
    • 7.1.1 North America Viscosupplementation Market by Application
      • 7.1.1.1 North America Knee Osteoarthritis Market by Country
      • 7.1.1.2 North America Hand Osteoarthritis Market by Country
      • 7.1.1.3 North America Hip Osteoarthritis Market by Country
      • 7.1.1.4 North America Others Market by Country
    • 7.1.2 North America Viscosupplementation Market by Product
      • 7.1.2.1 North America Three Injection Market by Country
      • 7.1.2.2 North America Single Injection Market by Country
      • 7.1.2.3 North America Five Injection Market by Country
    • 7.1.3 North America Viscosupplementation Market by End-use
      • 7.1.3.1 North America Hospitals Market by Country
      • 7.1.3.2 North America Orthopedic Clinics/ASCs Market by Country
    • 7.1.4 North America Viscosupplementation Market by Country
      • 7.1.4.1 US Viscosupplementation Market
        • 7.1.4.1.1 US Viscosupplementation Market by Application
        • 7.1.4.1.2 US Viscosupplementation Market by Product
        • 7.1.4.1.3 US Viscosupplementation Market by End-use
      • 7.1.4.2 Canada Viscosupplementation Market
        • 7.1.4.2.1 Canada Viscosupplementation Market by Application
        • 7.1.4.2.2 Canada Viscosupplementation Market by Product
        • 7.1.4.2.3 Canada Viscosupplementation Market by End-use
      • 7.1.4.3 Mexico Viscosupplementation Market
        • 7.1.4.3.1 Mexico Viscosupplementation Market by Application
        • 7.1.4.3.2 Mexico Viscosupplementation Market by Product
        • 7.1.4.3.3 Mexico Viscosupplementation Market by End-use
      • 7.1.4.4 Rest of North America Viscosupplementation Market
        • 7.1.4.4.1 Rest of North America Viscosupplementation Market by Application
        • 7.1.4.4.2 Rest of North America Viscosupplementation Market by Product
        • 7.1.4.4.3 Rest of North America Viscosupplementation Market by End-use
  • 7.2 Europe Viscosupplementation Market
    • 7.2.1 Europe Viscosupplementation Market by Application
      • 7.2.1.1 Europe Knee Osteoarthritis Market by Country
      • 7.2.1.2 Europe Hand Osteoarthritis Market by Country
      • 7.2.1.3 Europe Hip Osteoarthritis Market by Country
      • 7.2.1.4 Europe Others Market by Country
    • 7.2.2 Europe Viscosupplementation Market by Product
      • 7.2.2.1 Europe Three Injection Market by Country
      • 7.2.2.2 Europe Single Injection Market by Country
      • 7.2.2.3 Europe Five Injection Market by Country
    • 7.2.3 Europe Viscosupplementation Market by End-use
      • 7.2.3.1 Europe Hospitals Market by Country
      • 7.2.3.2 Europe Orthopedic Clinics/ASCs Market by Country
    • 7.2.4 Europe Viscosupplementation Market by Country
      • 7.2.4.1 Germany Viscosupplementation Market
        • 7.2.4.1.1 Germany Viscosupplementation Market by Application
        • 7.2.4.1.2 Germany Viscosupplementation Market by Product
        • 7.2.4.1.3 Germany Viscosupplementation Market by End-use
      • 7.2.4.2 UK Viscosupplementation Market
        • 7.2.4.2.1 UK Viscosupplementation Market by Application
        • 7.2.4.2.2 UK Viscosupplementation Market by Product
        • 7.2.4.2.3 UK Viscosupplementation Market by End-use
      • 7.2.4.3 France Viscosupplementation Market
        • 7.2.4.3.1 France Viscosupplementation Market by Application
        • 7.2.4.3.2 France Viscosupplementation Market by Product
        • 7.2.4.3.3 France Viscosupplementation Market by End-use
      • 7.2.4.4 Russia Viscosupplementation Market
        • 7.2.4.4.1 Russia Viscosupplementation Market by Application
        • 7.2.4.4.2 Russia Viscosupplementation Market by Product
        • 7.2.4.4.3 Russia Viscosupplementation Market by End-use
      • 7.2.4.5 Spain Viscosupplementation Market
        • 7.2.4.5.1 Spain Viscosupplementation Market by Application
        • 7.2.4.5.2 Spain Viscosupplementation Market by Product
        • 7.2.4.5.3 Spain Viscosupplementation Market by End-use
      • 7.2.4.6 Italy Viscosupplementation Market
        • 7.2.4.6.1 Italy Viscosupplementation Market by Application
        • 7.2.4.6.2 Italy Viscosupplementation Market by Product
        • 7.2.4.6.3 Italy Viscosupplementation Market by End-use
      • 7.2.4.7 Rest of Europe Viscosupplementation Market
        • 7.2.4.7.1 Rest of Europe Viscosupplementation Market by Application
        • 7.2.4.7.2 Rest of Europe Viscosupplementation Market by Product
        • 7.2.4.7.3 Rest of Europe Viscosupplementation Market by End-use
  • 7.3 Asia Pacific Viscosupplementation Market
    • 7.3.1 Asia Pacific Viscosupplementation Market by Application
      • 7.3.1.1 Asia Pacific Knee Osteoarthritis Market by Country
      • 7.3.1.2 Asia Pacific Hand Osteoarthritis Market by Country
      • 7.3.1.3 Asia Pacific Hip Osteoarthritis Market by Country
      • 7.3.1.4 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Viscosupplementation Market by Product
      • 7.3.2.1 Asia Pacific Three Injection Market by Country
      • 7.3.2.2 Asia Pacific Single Injection Market by Country
      • 7.3.2.3 Asia Pacific Five Injection Market by Country
    • 7.3.3 Asia Pacific Viscosupplementation Market by End-use
      • 7.3.3.1 Asia Pacific Hospitals Market by Country
      • 7.3.3.2 Asia Pacific Orthopedic Clinics/ASCs Market by Country
    • 7.3.4 Asia Pacific Viscosupplementation Market by Country
      • 7.3.4.1 China Viscosupplementation Market
        • 7.3.4.1.1 China Viscosupplementation Market by Application
        • 7.3.4.1.2 China Viscosupplementation Market by Product
        • 7.3.4.1.3 China Viscosupplementation Market by End-use
      • 7.3.4.2 Japan Viscosupplementation Market
        • 7.3.4.2.1 Japan Viscosupplementation Market by Application
        • 7.3.4.2.2 Japan Viscosupplementation Market by Product
        • 7.3.4.2.3 Japan Viscosupplementation Market by End-use
      • 7.3.4.3 India Viscosupplementation Market
        • 7.3.4.3.1 India Viscosupplementation Market by Application
        • 7.3.4.3.2 India Viscosupplementation Market by Product
        • 7.3.4.3.3 India Viscosupplementation Market by End-use
      • 7.3.4.4 South Korea Viscosupplementation Market
        • 7.3.4.4.1 South Korea Viscosupplementation Market by Application
        • 7.3.4.4.2 South Korea Viscosupplementation Market by Product
        • 7.3.4.4.3 South Korea Viscosupplementation Market by End-use
      • 7.3.4.5 Singapore Viscosupplementation Market
        • 7.3.4.5.1 Singapore Viscosupplementation Market by Application
        • 7.3.4.5.2 Singapore Viscosupplementation Market by Product
        • 7.3.4.5.3 Singapore Viscosupplementation Market by End-use
      • 7.3.4.6 Malaysia Viscosupplementation Market
        • 7.3.4.6.1 Malaysia Viscosupplementation Market by Application
        • 7.3.4.6.2 Malaysia Viscosupplementation Market by Product
        • 7.3.4.6.3 Malaysia Viscosupplementation Market by End-use
      • 7.3.4.7 Rest of Asia Pacific Viscosupplementation Market
        • 7.3.4.7.1 Rest of Asia Pacific Viscosupplementation Market by Application
        • 7.3.4.7.2 Rest of Asia Pacific Viscosupplementation Market by Product
        • 7.3.4.7.3 Rest of Asia Pacific Viscosupplementation Market by End-use
  • 7.4 LAMEA Viscosupplementation Market
    • 7.4.1 LAMEA Viscosupplementation Market by Application
      • 7.4.1.1 LAMEA Knee Osteoarthritis Market by Country
      • 7.4.1.2 LAMEA Hand Osteoarthritis Market by Country
      • 7.4.1.3 LAMEA Hip Osteoarthritis Market by Country
      • 7.4.1.4 LAMEA Others Market by Country
    • 7.4.2 LAMEA Viscosupplementation Market by Product
      • 7.4.2.1 LAMEA Three Injection Market by Country
      • 7.4.2.2 LAMEA Single Injection Market by Country
      • 7.4.2.3 LAMEA Five Injection Market by Country
    • 7.4.3 LAMEA Viscosupplementation Market by End-use
      • 7.4.3.1 LAMEA Hospitals Market by Country
      • 7.4.3.2 LAMEA Orthopedic Clinics/ASCs Market by Country
    • 7.4.4 LAMEA Viscosupplementation Market by Country
      • 7.4.4.1 Brazil Viscosupplementation Market
        • 7.4.4.1.1 Brazil Viscosupplementation Market by Application
        • 7.4.4.1.2 Brazil Viscosupplementation Market by Product
        • 7.4.4.1.3 Brazil Viscosupplementation Market by End-use
      • 7.4.4.2 Argentina Viscosupplementation Market
        • 7.4.4.2.1 Argentina Viscosupplementation Market by Application
        • 7.4.4.2.2 Argentina Viscosupplementation Market by Product
        • 7.4.4.2.3 Argentina Viscosupplementation Market by End-use
      • 7.4.4.3 UAE Viscosupplementation Market
        • 7.4.4.3.1 UAE Viscosupplementation Market by Application
        • 7.4.4.3.2 UAE Viscosupplementation Market by Product
        • 7.4.4.3.3 UAE Viscosupplementation Market by End-use
      • 7.4.4.4 Saudi Arabia Viscosupplementation Market
        • 7.4.4.4.1 Saudi Arabia Viscosupplementation Market by Application
        • 7.4.4.4.2 Saudi Arabia Viscosupplementation Market by Product
        • 7.4.4.4.3 Saudi Arabia Viscosupplementation Market by End-use
      • 7.4.4.5 South Africa Viscosupplementation Market
        • 7.4.4.5.1 South Africa Viscosupplementation Market by Application
        • 7.4.4.5.2 South Africa Viscosupplementation Market by Product
        • 7.4.4.5.3 South Africa Viscosupplementation Market by End-use
      • 7.4.4.6 Nigeria Viscosupplementation Market
        • 7.4.4.6.1 Nigeria Viscosupplementation Market by Application
        • 7.4.4.6.2 Nigeria Viscosupplementation Market by Product
        • 7.4.4.6.3 Nigeria Viscosupplementation Market by End-use
      • 7.4.4.7 Rest of LAMEA Viscosupplementation Market
        • 7.4.4.7.1 Rest of LAMEA Viscosupplementation Market by Application
        • 7.4.4.7.2 Rest of LAMEA Viscosupplementation Market by Product
        • 7.4.4.7.3 Rest of LAMEA Viscosupplementation Market by End-use

Chapter 8. Company Profiles

  • 8.1 DePuy Synthes (Johnson & Johnson)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental & Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Sanofi S.A.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Zimmer Biomet Holdings, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 SWOT Analysis
  • 8.4 Ferring Holdings SA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 Research and Development Expense
    • 8.4.5 SWOT Analysis
  • 8.5 F. Hoffmann-La Roche Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 SWOT Analysis
  • 8.6 LG Chem Ltd. (LG Corporation)
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 SWOT Analysis
  • 8.7 Anika Therapeutics, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis
  • 8.8 Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 SWOT Analysis
  • 8.9 Smith & Nephew PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional and Segmental Analysis
    • 8.9.4 Research & Development Expense
    • 8.9.5 SWOT Analysis
  • 8.10. Seikagaku Corp.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperative for Viscosupplementation Market